Skip to main content
. 2019 Oct 8;8(10):1221. doi: 10.3390/cells8101221

Figure 3.

Figure 3

Relative levels of miR-371a-3p (A), miR-373-3p (B) and miR-367-3p (C) before start of chemotherapy in cohort 1 and 2 combined in good (n = 67), intermediate (n = 25) or poor risk (n = 17) IGCCCG group. Relative levels of miR-371a-3p (D), miR-373-3p (E) and miR-367-3p (F) before start of chemotherapy in cohort 1 and 2 with complete response (CR, n = 60), relapse (R, n = 34) or refractory disease (RD, n = 15). The parameter p denotes Mann Whitney U test significance.